Breast cancer is the most common cancer among women worldwide. MammoAlert delivers an AI-powered breast cancer risk assessment from a simple finger-prick blood sample in less than 30 minutes — on a low-cost, portable instrument simple enough for any clinical or community setting.
Breast cancer is the most common cancer among women worldwide, yet routine screening remains out of reach for billions. MammoAlert is designed to expand access far beyond where mammography reaches today.
MammoAlert integrates five complementary protein biomarkers into a single, explainable AI risk result — designed to expand access to early detection for women everywhere, not replace mammography.
Explain consent & collect basic info
Personalize based on medical & family history
Analyze blood biomarkers in real time
Show biomarker test levels
Present AI-interpreted risk result
Explain next steps in plain language
A closer look at the guided app flow — from onboarding to an explained, actionable result.
Guided onboarding
Choose your data source
External lab results supported
Plain-language explanation
Built-in AI assistant
Clear next steps
Each biomarker tells part of the story. Harae Dx’s AI learns the relationships between five complementary biological pathways to generate one explainable cancer risk prediction.
Cell Signaling
A cell-signaling receptor protein associated with more aggressive tumor behavior when elevated.
Matrix Remodeling
An enzyme involved in tissue remodeling, tumor invasion, and metastasis.
Tumor Associated
A tumor-associated protein commonly elevated in breast cancer.
Inflammation
A protein involved in cell adhesion, immune response, and tumor progression.
Angiogenesis
A key driver of angiogenesis — the growth of new blood vessels that fuel tumors.
The Nidan BioLab system pairs a portable instrument with integrated AI analysis and a disposable microfluidic cartridge — designed for deployment in rural clinics, mobile units, and other low-infrastructure settings.
Integrated AI analysis on-device
Single-use microfluidic disk
Usable by any healthcare worker
From sample to actionable insight
Each single-use disk integrates five parallel assay channels — one per biomarker — on a compact, disposable platform. Precision-molded fluidic pathways route a single blood sample to each reaction site, enabling all five biomarker measurements from one draw, one disk, and one run.
